ArticleFrontiers in endocrinology2022

Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database.

Lulu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.